Integra Lifesciences Holdings Corp
NASDAQ:IART
Integra Lifesciences Holdings Corp
NASDAQ:IART
Price:
26.98 USD
-2.03%
Market Closed
Updated:
May 21, 2024
Integra Lifesciences Holdings Corp
Interest Income Expense
|
Integra Lifesciences Holdings Corp
Interest Income Expense Peer Comparison
Comparables:
BDX
BSX
SYK
ABT
ISRG
Competitive Interest Income Expense Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Interest Income Expense | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Integra Lifesciences Holdings Corp
NASDAQ:IART
|
Interest Income Expense
-$34.8m
|
CAGR 3-Years
6%
|
CAGR 5-Years
8%
|
CAGR 10-Years
-6%
|
|
|
Becton Dickinson and Co
NYSE:BDX
|
Interest Income Expense
-$375m
|
CAGR 3-Years
9%
|
CAGR 5-Years
11%
|
CAGR 10-Years
-15%
|
|
|
Boston Scientific Corp
NYSE:BSX
|
Interest Income Expense
-$554m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-51%
|
CAGR 10-Years
-6%
|
|
|
Stryker Corp
NYSE:SYK
|
Interest Income Expense
$97m
|
CAGR 3-Years
7%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
N/A
|
|
|
Abbott Laboratories
NYSE:ABT
|
Interest Income Expense
-$296m
|
CAGR 3-Years
16%
|
CAGR 5-Years
16%
|
CAGR 10-Years
-13%
|
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Interest Income Expense
$227m
|
CAGR 3-Years
11%
|
CAGR 5-Years
19%
|
CAGR 10-Years
29%
|
See Also
What is Integra Lifesciences Holdings Corp's Interest Income Expense?
Interest Income Expense
-34.8m
USD
-34.8m
USD
Based on the financial report for Mar 31, 2024, Integra Lifesciences Holdings Corp's Interest Income Expense amounts to -34.8m USD.
What is Integra Lifesciences Holdings Corp's Interest Income Expense growth rate?
Interest Income Expense CAGR 10Y
-6%
-6%
Over the last year, the Interest Income Expense growth was 2%. The average annual Interest Income Expense growth rates for Integra Lifesciences Holdings Corp have been 6% over the past three years , 8% over the past five years , and -6% over the past ten years .
You don't have any saved screeners yet
